Use of Inhaled Nitric Oxide in Preterm Infants: Is There Sufficient Evidence?

Stritzke, Amelie; Bhandari, Vineet; Lodha, Abhay

Stritzke, Amelie; Bhandari, Vineet; Lodha, Abhay.

Affiliation

Stritzke A; Department of Pediatrics, Foothills Medical Centre, 780-1403 29th St NW, Calgary, AB T2N 2T9, Canada. amelie.stritzke@albertahealthservices.ca.
Bhandari V; Libin Cardiovascular Institute of Alberta, University of Calgary, Calgary, Canada. amelie.stritzke@albertahealthservices.ca.
Lodha A; Alberta Health Services, Calgary, Canada. amelie.stritzke@albertahealthservices.ca.

Indian J Pediatr ; 89(3): 262-266, 2022 Mar.

Article in En | MEDLINE | ID: mdl-34287800

Subject(s)

Bronchopulmonary Dysplasia; Nitric Oxide; Administration, Inhalation; Bronchopulmonary Dysplasia/drug therapy; Humans; Infant, Newborn; Infant, Premature; Nitric Oxide/therapeutic use; Vasodilator Agents/therapeutic use

Key words

Nitric Oxide; Preterm infants; Pulmonary hypertension

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Bronchopulmonary Dysplasia / Nitric Oxide Limits: Humans / Newborn Language: En Journal: Indian J Pediatr Year: 2022 Document type: Article Affiliation country: Canada Country of publication: India

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google